From Molecules to Medicines: The Role of AI-Driven Drug Discovery Against Alzheimer’s Disease and Other Neurological Disorders
The discovery of effective therapeutics against Alzheimer’s disease (AD) and other neurological disorders remains a significant challenge. Artificial intelligence (AI) tools are of considerable interest in modern drug discovery processes and, by exploiting machine learning (ML) algorithms and deep l...
Saved in:
Main Author: | Mashael A. Alghamdi |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2025-07-01
|
Series: | Pharmaceuticals |
Subjects: | |
Online Access: | https://www.mdpi.com/1424-8247/18/7/1041 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Mass spectrometry‐based proteomics for biomarker discovery in the Drosophila model of Parkinson's disease
by: Mohammad Radid Khan, et al.
Published: (2024-12-01) -
AI-driven discovery of brain-penetrant Galectin-3 inhibitors for Alzheimer's disease therapy
by: Xueyan Liu, et al.
Published: (2025-08-01) -
Biomarkers and therapeutic targets in early Alzheimer’s disease: an Olink proteomics study
by: Jianan Wei, et al.
Published: (2025-07-01) -
Network Pharmacology-Driven Sustainability: AI and Multi-Omics Synergy for Drug Discovery in Traditional Chinese Medicine
by: Lifang Yang, et al.
Published: (2025-07-01) -
Generative AI for drug discovery and protein design: the next frontier in AI-driven molecular science
by: Uddalak Das
Published: (2025-09-01)